Mark A. McPartland

2019

In 2019, Mark A. McPartland earned a total compensation of $506.6K as Vice President, Corporate Development at Vistagen Therapeutics.

Compensation breakdown

Bonus$50,874
Option Awards$187,017
Salary$268,750
Total$506,641

McPartland received $268.8K in salary, accounting for 53% of the total pay in 2019.

McPartland also received $50.9K in bonus and $187K in option awards.

Rankings

In 2019, Mark A. McPartland's compensation ranked 11,729th out of 13,971 executives tracked by ExecPay. In other words, McPartland earned more than 16.0% of executives.

ClassificationRankingPercentile
All
11,729
out of 13,971
16th
Division
Manufacturing
4,751
out of 5,701
17th
Major group
Chemicals And Allied Products
1,875
out of 2,200
15th
Industry group
Drugs
1,616
out of 1,886
14th
Industry
Pharmaceutical Preparations
1,198
out of 1,398
14th
Source: SEC filing on July 27, 2020.

McPartland's colleagues

We found four more compensation records of executives who worked with Mark A. McPartland at Vistagen Therapeutics in 2019.

2019

Shawn Singh

Vistagen Therapeutics

Chief Executive Officer

2019

H Snodgrass

Vistagen Therapeutics

Chief Scientific Officer

2019

Mark Smith

Vistagen Therapeutics

Chief Medical Officer

2019

Jerrold Dotson

Vistagen Therapeutics

Chief Financial Officer

News

You may also like